Extrapleural pneumonectomy for malignant pleural mesothelioma: Outcomes of treatment and prognostic factors

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 3, 2009, Pages 619-624

  Yan, Tristan D ^a,b   Boyer, Michael ^a   Tin, Mo Mo ^a   Wong, Daniel ^a   Kennedy, Catherine ^a,b   McLean, Jocelyn ^a,b   Bannon, Paul G ^a,b   McCaughan, Brian C ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b Baird Institute for Applied Heart and Lung Surgical Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CARBOPLATIN; CISPLATIN; PEMETREXED;

ARTICLE; BRONCHOPULMONARY FISTULA; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONSTRICTIVE PERICARDITIS; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISSEMINATED INTRAVASCULAR CLOTTING; EMPYEMA; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEMATOTHORAX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG EDEMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERIOPERATIVE COMPLICATION; PLEURA MESOTHELIOMA; PLEURECTOMY; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SMALL INTESTINE HERNIA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLUTAMATES; GUANINE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MESOTHELIOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLEURAL NEOPLASMS; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 68749097032     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.12.045     Document Type: Article

References (27)

1. Butchart E., Ascroft T., Barnsley W., et al. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Thorax 31 (1976) 15-24
2. Branscheid D., Krysa S., Bauer E., et al. Diagnostic and therapeutic strategy in malignant pleural mesothelioma. Eur J Cardiothorac Surg 5 (1991) 466-473
3. Ruffie P., Feld R., Cormier M., et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 7 (1989) 1157-1168
4. Brancatisano R., Joseph M., and McCaughan B. Pleurectomy for mesothelioma. Med J Aust 154 (1991) 455-460
5. Rusch V., Piantadosi S., and Holmes E. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 102 (1991) 1-9
6. Sugarbaker D., Heher E., Lee T., et al. Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma. J Thorac Cardiovasc Surg 102 (1991) 10-15
7. Sugarbaker D., and Norberto J. Multimodality management of malignant pleural mesothelioma. Chest 113 (1998) 61-65
8. Rusch V.W., Rosenzweig K., Venkatraman E., et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122 (2001) 788-795
9. Yajnik S., Rosenzweig K.E., Mychalczak B., et al. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 56 (2003) 1319-1326
10. Sugarbaker D.J. Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol 1 (2006) 175-176
11. Flores R.M., Zakowski M., Venkatraman E., et al. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol 2 (2007) 957-965
12. Sugarbaker D.J., Jaklitsch M.T., Bueno R., et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 128 (2004) 138-146
13. de Perrot M., McRae K., Anraku M., et al. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma. Ann Thorac Surg 85 (2008) 1206-1210
14. Vogelzang N.J., Rusthoven J.J., Symanowski J., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 (2003) 2636-2644
15. Ceresoli G.L., Zucali P.A., Favaretto A.G., et al. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma. J Clin Oncol 24 (2006) 1443-1448
16. Castagneto B., Botta M., Aitini E., et al. Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM). Ann Oncol 19 (2008) 370-373
17. Rusch V., and Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 111 (1996) 815-826
18. Flores R., Routledge T., Seshan V.E., et al. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 136 (2008) 605-610
19. Christensen B., Godleski J., Roelofs C., et al. Asbestos burden predicts survival in pleural mesothelioma. Environ Health Perspect 116 (2008) 723-726
20. Sugarbaker D., Flores R., Jaklitsch M., et al. Resection margins, extrapleural nodal status and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117 (1999) 54-65
21. Edwards J.G., Stewart D.J., Martin-Ucar A., et al. The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma. J Thorac Cardiovasc Surg 131 (2006) 981-987
22. Flores R.M. Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience. Lung Cancer 49 Suppl 1 (2005) S71-S74
23. Rea F., Marulli G., Bortolotti L., et al. Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): feasibility and results. Lung Cancer 57 (2007) 89-95
24. Maziak D.E., Gagliardi A., Haynes A.E., et al. Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary. Lung Cancer 48 (2005) 157-169
25. Muers M., Stephens R., Fisher P., et al. Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial. Lancet 371 (2008) 1685-1694
26. Riquet M., Assouad J., Bagab P., et al. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg 79 (2005) 225-233
27. de Perrot M., Uy K., Anraku M., et al. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 133 (2007) 111-116